Navigation Links
JAZZ PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2013 FINANCIAL RESULTS
Date:8/6/2013

>734,176551,572Property and equipment, net

10,7687,281Intangible assets, net

822,976869,952Goodwill

439,014442,600Deferred tax assets, net, non-current

65,13674,850Deferred financing costs

16,30816,576Other long-term assets

5,5023,662Total assets

$   2,093,880$
,966,493LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities:Accounts payable

$
20,367$
5,887Accrued liabilities

96,771104,666Current portion of long-term debt 

5,57229,688Income taxes payable

17,53939,884Contingent consideration

42,700-Deferred tax liability, net

259275Deferred revenue

1,1381,138Total current liabilities

184,346191,538Deferred revenue, non-current

6,2836,776Long-term debt, less current portion 

546,724427,073Contingent consideration, non-current

-34,800Deferred tax liability, net, non-current

167,744178,393Other non-current liabilities

13,3306,621Total shareholders' equity 

1,175,4531,121,292Total liabilities and shareholders' equity 

$   2,093,880$
,966,493JAZZ PHARMACEUTICALS PLCRECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES(In thousands, except per share amounts)(Unaudited)Three Months EndedSix Months EndedJune 30,June 30,2013201220132012GAAP income from continuing operations

$
42,185$
31,113$
85,610$
,348Intangible asset amortization

19,39912,97038,95423,702Share-based compensation expense

11,5065,04820,2638,329Acquisition accounting inventory fair value step-up

1,0863,0322,6314,340Transaction and integration costs

71110,0941,73316,189Restructuring charges

5085471,457547Change in fair value of contingent consideration

3,4002007,900200Upfront license fees

--4,000-Depreciation

595-1,170-Loss on extinguishment and modification of debt

3,74
'/>"/>

SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Cumberland Pharmaceuticals Reports Second Quarter Financial Results
2. Inovio Pharmaceuticals Responds to Market Activity
3. UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position
4. Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Bausch + Lomb
5. Avanir Pharmaceuticals to Participate in Two Conferences in August
6. Imprimis Pharmaceuticals, Inc. to Present at the Southern California Investor Conference on Thursday, August 8, 2013 at the Island Hotel in Newport Beach, CA. The presentation is scheduled to begin at 11 a.m. ET / 8 a.m. PT
7. AcelRx Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference
8. Isis Pharmaceuticals Reports Data From a Phase 2 Study of Isis-CRP Rx in Patients with Rheumatoid Arthritis
9. Intercept Pharmaceuticals to Present at the Wedbush Securities Life Sciences Management Access Conference
10. GW Pharmaceuticals Announces Results of MS Spasticity Study Confirming Sativex Has No Long-Term Negative Effect on Cognition
11. GW Pharmaceuticals plc Reports 2013 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Calif. , Jan. 15, 2014 Massachusetts ... (NASDAQ: AMGN ) announced today that ... discover and validate new therapeutic targets and develop ... chronic disorder that affects millions worldwide. The MGH-Broad-Amgen ...
(Date:1/15/2014)...  In an unprecedented effort to curb the spread of "superbugs" such ... vehicles, an advanced and portable UV germicidal lamp manufactured by MRSA-UV ... In order to prevent EMS paramedics and transport ... West Palm Beach Fire Rescue is the first in ...
(Date:1/15/2014)... , Jan. 15, 2014  According to Millennium ... technology market intelligence, the United States ... (TEO) device markets will expand moderately through 2022, ... segments. In particular, increasing interest in drug-eluting beads ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... May 18, 2011 The Consumer Healthcare Products ... acetaminophen medicines for children, applauds the U.S. Food ... and caregivers give their children the right amount ... Committee and Pediatric Advisory Committee recommended enhancing the ...
... Kinetics, Inc. (NKI) ( www.neuro-kinetics.com ), manufacturers of ... neuro-otologic, vestibular and neurological testing, said today that ... control and analysis software. Clinical specialists ... conduct vestibular, oculomotor and optokinetic tests to detect ...
Cached Medicine Technology:OTC Industry Supports FDA Advisory Committee Recommendations on New Dosing Instructions 2OTC Industry Supports FDA Advisory Committee Recommendations on New Dosing Instructions 3Neuro Kinetics Releases Updated Version of Neuro-Otologic Control and Analysis Software 2
(Date:7/10/2014)... The benefits of medical imaging far outweigh the risks ... Way, with The Right Radiation Dose. However, overuse and ... Clinic is leading a collaborative effort to ensure a ... online in the Journal of Patient Safety , ... Commission, the Intersociety Accreditation Commission, and the Centers for ...
(Date:7/10/2014)... (July 10, 2014) A research review identifying the ... important first step in the process of developing evidence-based ... a new report published by Neurosurgery ... Neurological Surgeons . The journal is published by ... Wolters Kluwer Health . , Based on ...
(Date:7/10/2014)... localized prostate cancer were more likely to be ... effective treatments and survived for shorter times than ... UCLA study has found. , The negative outcomes ... as bias against the mentally ill, depression,s impact ... of investment in his general health and disinterest ...
(Date:7/10/2014)... new drug could prove useful in treating small cell lung ... Scientists from the Cancer Research UK Manchester Institute, based at ... Research Centre, teamed up with experts at AstraZeneca, as part ... known as AZD3965 - on small cell lung cancer ... Cancer Research , also helps identify which patients are most ...
(Date:7/9/2014)... 10, 2014 -- The World Health Organization recommends that ... moderate to vigorous physical activity (MVPA) each day. ... MVPA during school hours. Therefore, it stands to ... increase MVPA. In a new study scheduled for ... confirmed that time spent outdoors after school was positively ...
Breaking Medicine News(10 mins):Health News:Mayo Clinic calls for standardization of safe imaging protocols for children 2Health News:What's a concussion? Review identifies four evidence-based indicators 2Health News:What's a concussion? Review identifies four evidence-based indicators 3Health News:Depressed men with prostate cancer are diagnosed later stage, get less effective therapies 2Health News:New drug active against most aggressive type of lung cancer cells 2Health News:Go play outside! Outdoor time promotes physical activity in youth 2
... is,a leader in serving people who are visually impaired -- ... People who are legally blind can function and lead effectively ... The news that Lt. Gov. Paterson will become Governor ... people with vision loss can,achieve great heights., As I ...
... the finding shouldn,t keep physicians from using Avastin, researchers say ... cancer drug Avastin can cause kidney damage by doing what ... study shows. , Avastin, whose generic name is bevacizumab, is ... attack cancers by cutting off their blood supply. It does ...
... 12 As previously,disclosed in its Form 8-K filed ... NHWK ) announced that Ernest G. Ludy has resigned,from ... of Directors for,personal reasons. As a result of such ... with Nasdaq Marketplace Rule,4350(d)(2) -- which requires the company,s ...
... Omega T, an Omega 3 and Turmeric ... ... makers,of Conquer HA(TM), introduce the latest addition to their family of joint,relief ... T,is powerful natural anti-inflammatory formula containing Omega 3 and,Turmeric for double strength ...
... 2008) The American Society of Nephrology (ASN), in ... American Society of Pediatric Nephrology (ASPN), will celebrate the ... and patient advocates from across the nation will hold ... raise awareness of chronic kidney disease (CKD) as a ...
... observed that cancer cells perform energy metabolism in a way ... later, this observation was exploited by clinicians to better visualize ... not been known exactly how tumor cells perform this alternate ... essential for tumor growth. , Now, two papers appearing in ...
Cached Medicine News:Health News:Doctors See How Cancer Drug Can Damage Kidneys 2Health News:Doctors See How Cancer Drug Can Damage Kidneys 3Health News:Previously Disclosed Changes in Board Composition of NightHawk Radiology Holdings, Inc. Prompt Notice of Noncompliance from the Nasdaq Global Market 2Health News:The Makers of Conquer HA(TM) Launch All-Natural Double Strength Anti- Inflammatory Formula 2Health News:ASN members visit Capitol Hill to promote World Kidney Day and CKD awareness 2Health News:Study helps explain fundamental process of tumor growth 2Health News:Study helps explain fundamental process of tumor growth 3
The base of the staple is round and threaded to enable screwing onto the stapler. The base also has spikes. The legs of the staple are contoured to prevent the staple from backing out....
The staple fixation system provides a simple means of attaching tissue to bone....
... ORTHOSET Radiopaque Bone Cement ... system: a sterile,ampule containing bone ... pack, and a sterile polyethylene ... a peelable pouch. The interiors ...
... Cement consists of a two ... bone cement liquid within a ... polyethylene bag,containing bone cement powder ... interiors of the blister pack,and ...
Medicine Products: